PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-13.21%
Cash & equivalents declining -13.21% while AXSM's grows 22.74%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
No Data
No Data available this quarter, please select a different quarter.
-13.21%
Below half of AXSM's 22.74%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.76%
Other current assets growth < half of AXSM's 87.04%. David Dodd sees a leaner approach to short-term items.
-11.17%
Below half of AXSM's 23.94%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
7.73%
Below half AXSM's -29.21%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both AXSM and the company show zero Long-Term Investments Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.08%
Below half of AXSM's -1.29%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-10.65%
Below half of AXSM's 17.41%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-100.00%
Above 1.5x AXSM's -7.34%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-100.00%
Higher Short-Term Debt Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both AXSM and the company show zero Deferred Revenue (Current) Growth.
1577.51%
Exceeding 1.5x AXSM's 872.83%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-26.01%
Less than half of AXSM's 4.24%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Higher Deferred Tax Liabilities (Non-Current) Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-0.35%
Less than half of AXSM's 40.97%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
-6.06%
Less than half of AXSM's 24.99%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-3.82%
≥ 1.5x AXSM's -1.88%. David Dodd sees higher yoy retained profits than competitor.
100.00%
Higher AOCI Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-13.95%
Below half AXSM's 2.06%. Michael Burry sees potential underperformance in building shareholder capital.
-10.65%
Below half AXSM's 17.41%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
-100.00%
Both AXSM and the company show zero Total Investments Growth.
-4.69%
Less than half of AXSM's 56.02%. David Dodd sees less overall debt expansion vs. competitor.
13.42%
Above 1.5x AXSM's 6.94%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.